您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > EPZ004777(formate)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
EPZ004777(formate)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
EPZ004777(formate)图片
规格:98%
分子量:585.7
包装与价格:
包装价格(元)
500ug电议
1mg电议
5mg电议
10mg电议

产品介绍
A potent inhibitor of DOT1L
货号:ajcx24946
CAS:N/A
分子式:C28H41N7O4·CH2O2
分子量:585.7
溶解度:DMF: 10 mg/ml,DMSO: 10 mg/ml,Ethanol: 10 mg/ml,Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

EPZ004777 is a potent inhibitor of DOT1L (IC50= 400 pM) that selectively kills mixed lineage leukemia (MLL) cellsin vitroand prolongs survival in an MLL xenograft mouse model.1,2,3,4It displays >1,000-fold selectivity for DOT1L relative to a panel of histone methyltransferases.1DOT1L inhibition by EPZ004777 has also been shown to accelerate the reprogramming of somatic cells into induced pluripotent stem cells.5


1.Daigle, S.R., Olhava, E.J., Therkelsen, C.A., et al.Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitorCancer Cell.20(1)53-65(2011) 2.Chen, L., Deshpande, A.J., Banka, D., et al.Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1lLeukemia27(4)813-822(2013) 3.Deshpande, A.J., Chen, L., Fazio, M., et al.Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1lBlood121(13)2533-2541(2013) 4.Yu, W., Chory, E.J., Wernimont, A.K., et al.Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitorsNat. Commun.31288(2012) 5.Ye, J., Ge, J., Zhang, X., et al.Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compoundsCell Res.26(1)34-45(2016)